Two-year periodicity of respiratory syncytial virus epidemics in Switzerland

Infection

Volumn 31, Issue 2, 2003, Pages 75-80

  Duppenthaler, A ^a   Gorgievski Hrisoho, M ^a   Frey, U ^a   Aebi, C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

ARTICLE; CONTROLLED STUDY; EPIDEMIC; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; PEDIATRIC HOSPITAL; PERIODICITY; RESOURCE MANAGEMENT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SWITZERLAND; VIRUS INFECTION;

DISEASE OUTBREAKS; EPIDEMIOLOGIC STUDIES; HUMANS; INFANT; PERIODICITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SEASONS; SWITZERLAND; TIME FACTORS;

EID: 12444278578     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-3124-8     Document Type: Article

References (31)

1. Hall CB: Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-1928.
2. Glezen WA, Taber LL, Frank AL, Kasel JA: Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-546.
3. Prober CG: Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer. Pediatrics 1997;99:472-475.
4. Duppenthaler A, Gorgievski-Hrisoho M, Aebi C: Regional impact of prophylaxis with the monoclonal antibody palivizumab on hospitalizations for respiratory syncytial virus. Swiss Med Wkly 2001;131:146-151.
5. Sigurs N: Epidemiologic and clinical evidence of a respiratory syncytial virus - reactive airway disease link. Am J Respir Crit Care Med 2001;163:2-6.
6. Cunningham CK, McMillan JA, Gross SJ: Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics 1991;88:527-532.
7. The IMPACT study group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-537.
8. American Academy of Pediatrics: Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IVIG. Pediatrics 1998;102:1211-1216.
9. Aebi C, Nadal D, Kind C, Pfister R, Barazzone C, Hammer J: Konsensus Statement zur Prävention von Respiratory Syncytial Virus (RSV)-Infektionen bei Neugeborenen und Säuglingen mit dem humanisierten monoklonalen Antikörper Palivizumab (Synagis). Paediatrica 2000;11:37-45.
10. Berner R, Schwoerer F, Schumacher RF, Meder M, Forster J: Community and nosocomially acquired respiratory syncytial virus infection in a German pediatric hospital 1988 to 1999. Eur J Pediatr 2001;160:541-547.
11. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson U: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children 1979-1997. J Infect Dis 2001;183:16-22.
12. Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, Hildreth SW, Anderson U: Occurrence of groups A and B of respiratory syncytial virus over 15 years: epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 1990;162:1283-1290.
13. Brouard J, Freymuth F, Constantini S, Petitjean J, de Schrevel G, Duhamel JF: Prevalence et aspects cliniques de l'infection par les sous-types A et B du virus respiratoire syncytial. Arch Fr Pediatr 1993;50:639-643.
14. Sims DG, Downham MA, McQuillan J, Gardner PS: Respiratory syncytial virus infection in north-east England. Br Med J 1976;2: 1095-1098.
15. Anderson U, Parker RA, Strikas RL: Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths in infants and young children. J Infect Dis 1990;161:640-646.
16. Waris M: Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B. J Infect Dis 1991;163:464-469.
17. Anestad G: Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on virus interference. Epidemiol Infect 1987;99:523-531.
18. Eriksson M, Bennett R, Rotzen-Ostlund M, von Sydow M, Wirgart BZ: Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr 2002;91:593-598.
19. Reyes M, Eriksson M, Bennet R, Hedlung KO, Ehrnst A: Regular pattern of respiratory syncytial virus and rotavirus infections in relation to the weather in Stockholm 1984-1993. Clin Microbiol Infect 1997;3:640-646.
20. Foy HM, Cooney MK, Maletzky AJ: Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period. Am J Epidemiol 1973;97:80-92.
21. Monto AS, Bryan ER, Rhodes LM: The Tecumseh study of respiratory illness. VII. Futher observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections. Am J Epidemiol 1974;100:458-468.
22. Reese PE, Marchette NJ: Respiratory syncytial virus infection and prevalence of subgroups A and B in Hawaii. J Clin Microbiol 1991;29:2614-2615.
23. Lyon JL, Stoddard G, Ferguson D, Caravati M, Kaczmarek A, Thompson G, Hegmann K, Hegmann C: An every other year cyclic epidemic of infants hospitalized with respiratory syncytial virus. Pediatrics 1996;97:152-153.
24. Mufson MA, Levine HD,Wasil RE, Mocega-Gonzalez HE, Krause HE: Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol 1973;98:88-95.
25. Ørstavik I, Carlson KH, Halvorsen K: Respiratory syncytial virus infections in Oslo 1972-1978. I. Virological and epidemiological studies. Acta Paediatr Scand 1980;69:717-722.
26. Peret TC, Hall CB, Hammond GW, Piedre PA, Storch GA, Sullender WM, Tsou C, Anderson LI: Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis 2000;181:1891-1896.
27. Brandenburg AH, van Beek R, Moll HA, Osterhaus ADME, Claas ECJ: G protein variation in respiratory syncytial virus group A does not correlate with clinical severity. J Clin Microbiol 2000; 38: 3849-3852.
28. Weber A, Weber M, Milligan P: Modeling epidemics caused by respiratory syncytial virus (RSV). Math Biosci 2001;172:95-113.
29. Weigl JA, Puppe W, Schmitt HJ: Incidence of respiratory syncytial virus-positive hospitalizations in Germany. Eur J Clin Microbiol Infect Dis 2001;20:452-459.
30. Martin AJ, Gardner PS, McQuillin J: Epidemiology of respiratory viral infection among paediatric inpatients over a six-year period in north-east England. Lancet 1978;2:1035-1038.
31. Florman AL, McLaren LC:The effect of altitude and weather on the occurrence of outbreaks of respiratory syncytial virus infections. J Infect Dis 1988;158:1401-1402.